JP2009539082A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539082A5
JP2009539082A5 JP2009512511A JP2009512511A JP2009539082A5 JP 2009539082 A5 JP2009539082 A5 JP 2009539082A5 JP 2009512511 A JP2009512511 A JP 2009512511A JP 2009512511 A JP2009512511 A JP 2009512511A JP 2009539082 A5 JP2009539082 A5 JP 2009539082A5
Authority
JP
Japan
Prior art keywords
affinity ligand
protein
satb2 protein
satb2
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009512511A
Other languages
English (en)
Japanese (ja)
Other versions
JP4990970B2 (ja
JP2009539082A (ja
Filing date
Publication date
Priority claimed from EP06114954A external-priority patent/EP1862803A1/en
Application filed filed Critical
Publication of JP2009539082A publication Critical patent/JP2009539082A/ja
Publication of JP2009539082A5 publication Critical patent/JP2009539082A5/ja
Application granted granted Critical
Publication of JP4990970B2 publication Critical patent/JP4990970B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009512511A 2006-06-02 2007-06-04 結腸直腸癌のためのマーカーとしてのタンパク質satb2の使用 Active JP4990970B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06114954.8 2006-06-02
EP06114954A EP1862803A1 (en) 2006-06-02 2006-06-02 Use of protein SATB2 as a marker for colorectal cancer
US81661306P 2006-06-27 2006-06-27
US60/816,613 2006-06-27
PCT/EP2007/004931 WO2007140966A1 (en) 2006-06-02 2007-06-04 Use of protein satb2 as a marker for colorectal cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011237699A Division JP5301630B2 (ja) 2006-06-02 2011-10-28 結腸直腸癌のためのマーカーとしてのタンパク質satb2の使用

Publications (3)

Publication Number Publication Date
JP2009539082A JP2009539082A (ja) 2009-11-12
JP2009539082A5 true JP2009539082A5 (enExample) 2010-07-22
JP4990970B2 JP4990970B2 (ja) 2012-08-01

Family

ID=36968849

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009512511A Active JP4990970B2 (ja) 2006-06-02 2007-06-04 結腸直腸癌のためのマーカーとしてのタンパク質satb2の使用
JP2011237699A Expired - Fee Related JP5301630B2 (ja) 2006-06-02 2011-10-28 結腸直腸癌のためのマーカーとしてのタンパク質satb2の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011237699A Expired - Fee Related JP5301630B2 (ja) 2006-06-02 2011-10-28 結腸直腸癌のためのマーカーとしてのタンパク質satb2の使用

Country Status (11)

Country Link
US (3) US8067190B2 (enExample)
EP (3) EP1862803A1 (enExample)
JP (2) JP4990970B2 (enExample)
CN (2) CN103293307B (enExample)
AT (2) ATE514090T1 (enExample)
AU (1) AU2007256391B2 (enExample)
CA (1) CA2653952A1 (enExample)
DK (2) DK2024747T3 (enExample)
ES (1) ES2367412T3 (enExample)
PL (1) PL2211180T3 (enExample)
WO (1) WO2007140966A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100662821B1 (ko) * 2006-04-05 2006-12-28 유니트마 주식회사 레시피언트 블록 성형용 몰드 및 이를 이용한 레시피언트블록의 제조방법
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
EP2107375A1 (en) * 2008-03-31 2009-10-07 Atlas Antibodies AB Uses of WARS protein in cancer prognostics
EP2172477A1 (en) * 2008-10-06 2010-04-07 Atlas Antibodies AB Epitopes derived from SATB2 and uses thereof
EP2396657B1 (en) * 2009-02-16 2013-11-13 Atlas Antibodies AB Rbm3 as a marker for malignant melanoma prognosis
CA2948548C (en) * 2014-05-13 2022-06-28 Vastcon Methionine aminopeptidase overexpression in the peripheral blood and peripheral blood mononuclear cells is a marker for colorectal cancer screening, diagnosis and prognosis
US11326210B2 (en) * 2015-01-30 2022-05-10 Glax Llc Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
US20160258438A1 (en) * 2015-03-05 2016-09-08 Regal Beloit America, Inc. Assembly, blower and associated method
WO2016176446A2 (en) * 2015-04-29 2016-11-03 Geneoscopy, Llc Colorectal cancer screening method and device
WO2018081580A1 (en) 2016-10-27 2018-05-03 Geneoscopy, Llc Detection method
CN106841131A (zh) * 2016-12-29 2017-06-13 上海交通大学 一种基于角蛋白自荧光作为预测检测肿瘤的生物标志物的检测方法及其应用
CA3136405A1 (en) 2018-06-01 2019-12-05 Geneoscopy, Inc. Detection method for cancer using rna biomarkers
US20210262041A1 (en) * 2018-08-08 2021-08-26 Indian Institute Of Science Education And Research Combined expression pattern of satb family chromatin organizers as improved biomarker tool for cancer prognosis
US12435335B2 (en) 2022-06-06 2025-10-07 Cornell University Promoting nutrient absorption through the colon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828840D0 (en) 1998-12-30 1999-02-17 Univ Nottingham Trent Prostate cancer associated genes and their products
DE19932688B4 (de) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
WO2003022126A2 (en) * 2001-08-21 2003-03-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20090215711A1 (en) * 2004-04-30 2009-08-27 Sagres Discovery, Inc. Novel compositions and methods in cancer
DE102004037860A1 (de) 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
US7932032B2 (en) * 2005-05-02 2011-04-26 Toray Industries, Inc. Method for diagnosing esophageal cancer
GB2435882A (en) 2006-03-09 2007-09-12 Bioinvent Int Ab Detection and treatment of mantle cell lymphoma
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer

Similar Documents

Publication Publication Date Title
JP2009539082A5 (enExample)
JP2012073260A5 (enExample)
Wang et al. Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles
ES2641294T3 (es) Nuevo anticuerpo para el diagnóstico y/o el pronóstico del cáncer
JP2009504142A5 (enExample)
JP2008249727A5 (enExample)
CA2844033C (en) Method for detecting pancreatic cancer
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
HRP20201856T1 (hr) Antitijela koja se vežu za ljudski ligand i programiranje smrti (pd-l1)
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ607703A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX337991B (es) Metodo para detectar cancer.
WO2005089524A3 (en) Compositions and methods for detection of single molecules
JP2013523151A5 (enExample)
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
JP2009521215A5 (enExample)
JP2015533788A5 (enExample)
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO2009019365A3 (fr) Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal
JP2015531768A5 (enExample)
EP3828284A1 (en) One-step procedure for the purification of nucleic acids
WO2009019367A3 (fr) Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
WO2002037112A3 (en) Detection of ovarian cancer
JP2017520763A5 (enExample)
JP2017538412A5 (enExample)